These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 2476583

  • 1. [Non-testicular germ cell tumors: analysis of the therapy study MAKEI 83/86 anc changes in the protocol for the follow-up study].
    Göbel U, Bamberg M, Haas RJ, Bökkerink JP, Brämswig G, Calaminus G, Engert J, Gadner H, Havers W, Janka-Schaub GE.
    Klin Padiatr; 1989; 201(4):247-60. PubMed ID: 2476583
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
    Göbel U, Bamberg M, Engert J, Gnekow AK, Haas HJ, Jürgens H, Kühl J, Lenard HG, Lumenta C, Niethammer D.
    Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
    [Abstract] [Full Text] [Related]

  • 3. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
    Göbel U, Calaminus G, Teske C, Bamberg M, Bökkerink JP, Haas RJ, Holschneider AM, Janka-Schaub G, Jürgens H, Mittler U.
    Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
    [Abstract] [Full Text] [Related]

  • 4. [Improved prognosis of intracranial germ cell tumors by intensified therapy: results of the MAKEI 89 therapy protocol].
    Göbel U, Bamberg M, Calaminus G, Gnekow AK, Herrmann HD, Lenard HG, Spaar HJ, Niethammer D, Kühl J, Harms D.
    Klin Padiatr; 1993; 205(4):217-24. PubMed ID: 7690863
    [Abstract] [Full Text] [Related]

  • 5. [Intracranial germ cell tumors: analysis of the therapy study MAKEI 83/86 and changes in protocol for the follow-up study].
    Göbel U, Bamberg M, Budach V, Haas RJ, Janka-Schaub G, Kühl J, Lenard HG, Rister M, Spaar HJ.
    Klin Padiatr; 1989; 201(4):261-8. PubMed ID: 2476584
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P, Haas RJ, Göbel U, Calaminus G.
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [Abstract] [Full Text] [Related]

  • 8. Testicular germ cell tumors. Results of the GPO MAHO studies -82, -88, -92.
    Haas RJ, Schmidt P, Göbel U, Harms D.
    Klin Padiatr; 1995; 207(4):145-50. PubMed ID: 7564144
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Therapy of testicular germ cell tumors. Current status of the MAHO studies].
    Haas RJ, Schmidt P, Göbel U, Harms D.
    Klin Padiatr; 1993; 205(4):225-30. PubMed ID: 8397320
    [Abstract] [Full Text] [Related]

  • 11. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G, Bamberg M, Jürgens H, Kortmann RD, Sörensen N, Wiestler OD, Göbel U.
    Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, Rogers PC, Colombani P, Rescorla F, Billmire DF, Vinocur CD, Hawkins EP, Davis MM, Perlman EJ, London WB, Castleberry RP, Pediatric Oncology Group 9049, Children's Cancer Group 8882.
    J Clin Oncol; 2004 Jul 01; 22(13):2691-700. PubMed ID: 15226336
    [Abstract] [Full Text] [Related]

  • 14. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group.
    J Clin Oncol; 2003 Nov 15; 21(22):4083-91. PubMed ID: 14568987
    [Abstract] [Full Text] [Related]

  • 15. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Nov 15; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 16. Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study.
    Mardiak J, Sálek T, Sycová-Milá Z, Obertová J, Recková M, Mego M, Hlavatá Z, Brozmanová K, Risnyovzská Z, Svetlovská D, Koza I.
    Neoplasma; 2007 Nov 15; 54(3):240-5. PubMed ID: 17447857
    [Abstract] [Full Text] [Related]

  • 17. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF, Yang QY, Zhen ZJ, Xia Y, Huang ZH, Ling JY.
    Ai Zheng; 2006 Dec 15; 25(12):1529-32. PubMed ID: 17166380
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
    Li J, Yang W, Wu X.
    Gynecol Oncol; 2007 Jun 15; 105(3):769-75. PubMed ID: 17459461
    [Abstract] [Full Text] [Related]

  • 19. Testicular germ cell tumors, an update. Results of the German cooperative studies 1982-1997.
    Haas RJ, Schmidt P, Göbel U, Harms D.
    Klin Padiatr; 1999 Jun 15; 211(4):300-4. PubMed ID: 10472566
    [Abstract] [Full Text] [Related]

  • 20. [New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
    Ikeda I, Shuin T, Yao M, Kubota Y, Hosaka M.
    Hinyokika Kiyo; 1993 Mar 15; 39(3):237-42. PubMed ID: 7685142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.